LEWY BODY DISEASE
Clinical trials for LEWY BODY DISEASE explained in plain language.
Never miss a new study
Get alerted when new LEWY BODY DISEASE trials appear
Sign up with your email to follow new studies for LEWY BODY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets dual brain proteins to slow lewy body dementia
Disease control Not yet recruitingThis study tests whether the drug donanemab can slow down worsening of thinking and daily living skills in people with early cognitive decline who also have signs of Lewy body dementia and Alzheimer's-related brain changes. About 350 participants will receive either donanemab or …
Matched conditions: LEWY BODY DISEASE
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
Wearable sensors aim to monitor brain disease symptoms at home
Knowledge-focused Not yet recruitingThis study tests whether wearable sensors can accurately monitor movement and daily function in people with progressive supranuclear palsy (PSP) and Lewy body dementia. About 60 participants will wear sensors on their chest, ankles, and wrists during clinic tests and for 14 days …
Matched conditions: LEWY BODY DISEASE
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated May 17, 2026 00:25 UTC